Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort study

Published:2023-11-07 Issue: Volume: Page:
ISSN:1358-863X
Container-title:Vascular Medicine
language:en
Short-container-title:Vasc Med

Author:

Dari Loubna¹²^ORCID,Constans Joël¹,Boulon Carine¹,Caradu Caroline³,Lapébie François-Xavier⁴,Bura-Rivière Alessandra⁴,Chastaingt Lucie⁵,Lacroix Philippe⁵,Bezin Julien²,Pariente Antoine²

Affiliation:

1. Department of Vascular Medicine, Bordeaux University Hospital, Bordeaux, France

2. Inserm U1219 Bordeaux Population Health Team AHeaD: Assessing Health in a Digitalizing Real-World Setting Pharmacoepi and beyond, University of Bordeaux, Bordeaux, France

3. Department of Vascular Surgery, Bordeaux University Hospital, Bordeaux, France

4. Department of Vascular Medicine, Toulouse University Hospital, Toulouse, France

5. Department of Vascular Medicine, Limoges University Hospital, Limoges, France

Funder

Sanofi Pasteur

Bristol-Myers Squibb

Bayer

Société Française de Médecine Vasculaire

AstraZeneca France

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1358863X231209263

Reference9 articles.

1. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

2. ESVM Guideline on peripheral arterial disease

3. Characteristics and Outcome of Patients Hospitalised for Lower Extremity Peripheral Artery Disease in France: The COPART Registry

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of iloprost in patients with critical limb ischemia: Results of a cohort study from the COPART registry;JMV-Journal de Médecine Vasculaire;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3